Core Viewpoint - The company, Norsker, is experiencing a decline in stock price and has a lower PE ratio compared to the industry average, indicating potential challenges in its market position and performance [1][2]. Company Summary - Norsker's closing stock price is 50.65 yuan, down 2.61%, with a rolling PE ratio of 34.15 times and a total market capitalization of 4.892 billion yuan [1]. - The company operates in the medical services industry, which has an average PE ratio of 40.82 times and a median of 45.93 times, placing Norsker at the 24th position within the industry [1][2]. - As of the first quarter of 2025, 12 institutions hold shares in Norsker, including 7 funds and 5 other entities, with a total holding of 32.7994 million shares valued at 1.685 billion yuan [1]. Financial Performance - For the first quarter of 2025, Norsker reported revenue of 173 million yuan, a year-on-year decrease of 2.53%, while net profit was 26.0737 million yuan, reflecting a year-on-year increase of 13.12% [1]. - The company's gross profit margin stands at 36.53% [1].
诺思格收盘下跌2.61%,滚动市盈率34.15倍,总市值48.92亿元